FI67081C - Analogifoerfarande foer framstaellning av ergolinderivat - Google Patents
Analogifoerfarande foer framstaellning av ergolinderivat Download PDFInfo
- Publication number
- FI67081C FI67081C FI803736A FI803736A FI67081C FI 67081 C FI67081 C FI 67081C FI 803736 A FI803736 A FI 803736A FI 803736 A FI803736 A FI 803736A FI 67081 C FI67081 C FI 67081C
- Authority
- FI
- Finland
- Prior art keywords
- group
- methyl
- ergoline
- oxymethyl
- eller
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 74
- 238000000034 method Methods 0.000 claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000000935 antidepressant agent Substances 0.000 claims description 5
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 229940005513 antidepressants Drugs 0.000 claims description 4
- 239000002249 anxiolytic agent Substances 0.000 claims description 4
- 230000000949 anxiolytic effect Effects 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 230000000701 neuroleptic effect Effects 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
- 150000001447 alkali salts Chemical class 0.000 claims description 2
- 230000001430 anti-depressive effect Effects 0.000 claims description 2
- 229940005530 anxiolytics Drugs 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 150000002894 organic compounds Chemical class 0.000 claims 2
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical group [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 239000003176 neuroleptic agent Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 description 41
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 description 35
- AWFDCTXCTHGORH-HGHGUNKESA-N 6-[4-[(6ar,9r,10ar)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carbonyl]piperazin-1-yl]-1-methylpyridin-2-one Chemical class O=C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC(Br)=C(C=34)C2)C1)C)N(CC1)CCN1C1=CC=CC(=O)N1C AWFDCTXCTHGORH-HGHGUNKESA-N 0.000 description 24
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 24
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 11
- LOGSONSNCYTHPS-UHFFFAOYSA-N cyclopentane-1,3-dione Chemical compound O=C1CCC(=O)C1 LOGSONSNCYTHPS-UHFFFAOYSA-N 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- PKQIDSVLSKFZQC-UHFFFAOYSA-N 3-oxobutanal Chemical compound CC(=O)CC=O PKQIDSVLSKFZQC-UHFFFAOYSA-N 0.000 description 6
- 230000002631 hypothermal effect Effects 0.000 description 6
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 5
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 5
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 5
- 230000008485 antagonism Effects 0.000 description 5
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 5
- 229960003147 reserpine Drugs 0.000 description 5
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 5
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 4
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 229940025084 amphetamine Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- ZFDIRQKJPRINOQ-UHFFFAOYSA-N ethyl but-2-enoate Chemical compound CCOC(=O)C=CC ZFDIRQKJPRINOQ-UHFFFAOYSA-N 0.000 description 4
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000007059 acute toxicity Effects 0.000 description 3
- 231100000403 acute toxicity Toxicity 0.000 description 3
- 206010005159 blepharospasm Diseases 0.000 description 3
- 230000000744 blepharospasm Effects 0.000 description 3
- NKKMVIVFRUYPLQ-UHFFFAOYSA-N but-2-enenitrile Chemical compound CC=CC#N NKKMVIVFRUYPLQ-UHFFFAOYSA-N 0.000 description 3
- 238000006482 condensation reaction Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- UKVYVZLTGQVOPX-IHWYPQMZSA-N (z)-3-aminobut-2-enoic acid Chemical compound C\C(N)=C\C(O)=O UKVYVZLTGQVOPX-IHWYPQMZSA-N 0.000 description 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- FUJZJBCWPIOHHN-UHFFFAOYSA-N 1-phenylbut-2-en-1-one Chemical compound CC=CC(=O)C1=CC=CC=C1 FUJZJBCWPIOHHN-UHFFFAOYSA-N 0.000 description 2
- HZGRXIZZCGADDT-XTAYQOGCSA-N 3-[[(6ar,9s)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-9-yl]methylamino]cyclopent-2-en-1-one Chemical compound C([C@H]1CN([C@H]2C(C=3C=CC=C4N(C)C=C(C=34)C2)C1)C)NC1=CC(=O)CC1 HZGRXIZZCGADDT-XTAYQOGCSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DEHHSXGUVDBSAH-BSLALVQMSA-N [(6ar,9r,10ar)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-yl]methyl 4-methylbenzenesulfonate Chemical compound C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC=C(C=34)C2)C1)C)OS(=O)(=O)C1=CC=C(C)C=C1 DEHHSXGUVDBSAH-BSLALVQMSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- -1 cyano, pyridyl Chemical group 0.000 description 2
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical compound O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- OSLAYKKXCYSJSF-ARJAWSKDSA-N (Z)-4-aminopent-3-en-2-one Chemical compound C\C(N)=C\C(C)=O OSLAYKKXCYSJSF-ARJAWSKDSA-N 0.000 description 1
- JIAGEKWBOSYIBM-UHFFFAOYSA-N 1-(2-aminocyclohexen-1-yl)ethanone Chemical compound CC(=O)C1=C(N)CCCC1 JIAGEKWBOSYIBM-UHFFFAOYSA-N 0.000 description 1
- ZAVHBBVUMWAKJI-UHFFFAOYSA-N 1-cyclohex-2-en-1-ylethanone Chemical compound CC(=O)C1CCCC=C1 ZAVHBBVUMWAKJI-UHFFFAOYSA-N 0.000 description 1
- CVBUKMMMRLOKQR-UHFFFAOYSA-N 1-phenylbutane-1,3-dione Chemical compound CC(=O)CC(=O)C1=CC=CC=C1 CVBUKMMMRLOKQR-UHFFFAOYSA-N 0.000 description 1
- MLIREBYILWEBDM-UHFFFAOYSA-M 2-cyanoacetate Chemical compound [O-]C(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-M 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- LOCGMUCCTDQHKW-ZEMWXQFSSA-N 3-[[(6ar,9r)-5,7-dimethyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-yl]methoxy]cyclopent-2-en-1-one Chemical compound C([C@H]1CN([C@H]2C(C=3C=CC=C4NC(C)=C(C=34)C2)C1)C)OC1=CC(=O)CC1 LOCGMUCCTDQHKW-ZEMWXQFSSA-N 0.000 description 1
- VPGKKBORKPVHMP-GYMYDKHPSA-N 3-[[(6ar,9r)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-yl]methoxy]cyclopent-2-en-1-one Chemical compound C([C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)C1)C)OC1=CC(=O)CC1 VPGKKBORKPVHMP-GYMYDKHPSA-N 0.000 description 1
- PTYAXFNVTJYDMK-BTQZEYGESA-N 3-[[(6ar,9s)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-yl]methylamino]cyclopent-2-en-1-one Chemical compound C([C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)C1)C)NC1=CC(=O)CC1 PTYAXFNVTJYDMK-BTQZEYGESA-N 0.000 description 1
- CDFSTMGURUSUMJ-UHFFFAOYSA-N 3-amino-1,3-diphenylprop-2-en-1-one Chemical compound C=1C=CC=CC=1C(N)=CC(=O)C1=CC=CC=C1 CDFSTMGURUSUMJ-UHFFFAOYSA-N 0.000 description 1
- GHPWHAXKMNDINZ-UHFFFAOYSA-N 3-amino-1-phenylbut-2-en-1-one Chemical compound CC(N)=CC(=O)C1=CC=CC=C1 GHPWHAXKMNDINZ-UHFFFAOYSA-N 0.000 description 1
- ZZMRPOAHZITKBV-UHFFFAOYSA-N 3-aminocyclohex-2-en-1-one Chemical compound NC1=CC(=O)CCC1 ZZMRPOAHZITKBV-UHFFFAOYSA-N 0.000 description 1
- LSROXAYPMFICCA-UHFFFAOYSA-N 3-aminocyclopent-2-en-1-one Chemical compound NC1=CC(=O)CC1 LSROXAYPMFICCA-UHFFFAOYSA-N 0.000 description 1
- NQYSMDDFEAGOMS-UHFFFAOYSA-N 3-oxobutanal;sodium Chemical compound [Na].CC(=O)CC=O NQYSMDDFEAGOMS-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 description 1
- RZHSOODALQZGFQ-XXBNENTESA-N CC(C=C1)=CC=C1S(OC[C@@](CC1=C(N2)Cl)([C@H](CCC3)C4=C1C2=CC=C4)N3OC)(=O)=O Chemical compound CC(C=C1)=CC=C1S(OC[C@@](CC1=C(N2)Cl)([C@H](CCC3)C4=C1C2=CC=C4)N3OC)(=O)=O RZHSOODALQZGFQ-XXBNENTESA-N 0.000 description 1
- HRYPWNLJTFZXHZ-VPPMAKIDSA-N CC1=CC=C(C=C1)S(=O)(=O)OCC23C[C@@H]4[C@H](CCCN4OC)C5=C2C(=CC=C5)N=C3 Chemical compound CC1=CC=C(C=C1)S(=O)(=O)OCC23C[C@@H]4[C@H](CCCN4OC)C5=C2C(=CC=C5)N=C3 HRYPWNLJTFZXHZ-VPPMAKIDSA-N 0.000 description 1
- KGJNRQBGPFKOMY-NDIGNCCYSA-N CC1=CC=C(C=C1)S(=O)(=O)OCC23C[C@@H]4[C@H](CCCN4OC)C5=C2C(=CC=C5)N=C3Br Chemical compound CC1=CC=C(C=C1)S(=O)(=O)OCC23C[C@@H]4[C@H](CCCN4OC)C5=C2C(=CC=C5)N=C3Br KGJNRQBGPFKOMY-NDIGNCCYSA-N 0.000 description 1
- AKTUYSPADITYJU-NKDCDXMNSA-N CC1=CC=C(C=C1)S(=O)(=O)OCC2CCN([C@H]3[C@H]2C4=C5C(=C(NC5=CC=C4)OC)C3)OC Chemical compound CC1=CC=C(C=C1)S(=O)(=O)OCC2CCN([C@H]3[C@H]2C4=C5C(=C(NC5=CC=C4)OC)C3)OC AKTUYSPADITYJU-NKDCDXMNSA-N 0.000 description 1
- SVLHXAVXTBQDNY-ZJSXRUAMSA-N CC1=CC=C(C=C1)S(=O)(=O)OCN2CCC[C@H]3[C@]2(CC4=C(NC5=CC=CC3=C45)C)C Chemical compound CC1=CC=C(C=C1)S(=O)(=O)OCN2CCC[C@H]3[C@]2(CC4=C(NC5=CC=CC3=C45)C)C SVLHXAVXTBQDNY-ZJSXRUAMSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 229920003091 Methocel™ Polymers 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- HCTJYFDTHFKFFR-IKQMYLSPSA-N [(6ar,10ar)-6a,7,8,9,10,10a-hexahydro-6h-indolo[4,3-fg]quinoline-5a-yl]methyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1(C[C@@H]2[C@@H]3CCCN2)C=NC2=C1C3=CC=C2 HCTJYFDTHFKFFR-IKQMYLSPSA-N 0.000 description 1
- NQOAVAOTTOTGFW-ODOSVJCGSA-N [(6ar,9r,10ar)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-9-yl]methyl 4-methylbenzenesulfonate Chemical compound C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4N(C)C=C(C=34)C2)C1)C)OS(=O)(=O)C1=CC=C(C)C=C1 NQOAVAOTTOTGFW-ODOSVJCGSA-N 0.000 description 1
- ZBWYRQSXZFXUBY-IHLLOCCUSA-N [(6ar,9r,10ar)-7-propyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-yl]methyl 4-methylbenzenesulfonate Chemical compound C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC=C(C=34)C2)C1)CCC)OS(=O)(=O)C1=CC=C(C)C=C1 ZBWYRQSXZFXUBY-IHLLOCCUSA-N 0.000 description 1
- XMVAISYXWMEOTD-MQVPCNEGSA-N [(6ar,9r,10as)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6h-indolo[4,3-fg]quinoline-9-yl]methyl 4-methylbenzenesulfonate Chemical compound C([C@@H]1C[C@]2([C@H](N(C)C1)CC=1C3=C2C=CC=C3N(C)C=1)OC)OS(=O)(=O)C1=CC=C(C)C=C1 XMVAISYXWMEOTD-MQVPCNEGSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001263 anti-prolactin effect Effects 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical compound O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- OIMXTYUHMBQQJM-UHFFFAOYSA-N ergone Natural products C1=CC2=CC(=O)CCC2(C)C2C1=C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OIMXTYUHMBQQJM-UHFFFAOYSA-N 0.000 description 1
- OIMXTYUHMBQQJM-HSVWHVBGSA-N ergosta-4,6,8(14),22-tetraen-3-one Chemical compound C1=CC2=CC(=O)CC[C@]2(C)[C@@H]2C1=C1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OIMXTYUHMBQQJM-HSVWHVBGSA-N 0.000 description 1
- 101150058626 gcH3 gene Proteins 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229960004801 imipramine Drugs 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000006431 methyl cyclopropyl group Chemical group 0.000 description 1
- IXRNQIKIVWWFBH-UHFFFAOYSA-N n-(1-phenylethenyl)acetamide Chemical compound CC(=O)NC(=C)C1=CC=CC=C1 IXRNQIKIVWWFBH-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 102200024849 rs201108965 Human genes 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7942079 | 1979-12-06 | ||
| GB7942079 | 1979-12-06 | ||
| GB8007029 | 1980-03-01 | ||
| GB8007029 | 1980-03-01 | ||
| GB8017518 | 1980-05-29 | ||
| GB8017518 | 1980-05-29 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI803736L FI803736L (fi) | 1981-06-07 |
| FI67081B FI67081B (fi) | 1984-09-28 |
| FI67081C true FI67081C (fi) | 1985-01-10 |
Family
ID=27260819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI803736A FI67081C (fi) | 1979-12-06 | 1980-12-02 | Analogifoerfarande foer framstaellning av ergolinderivat |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4382940A (da) |
| EP (1) | EP0030351B1 (da) |
| AU (1) | AU537581B2 (da) |
| CA (1) | CA1153367A (da) |
| DE (1) | DE3068911D1 (da) |
| DK (1) | DK518580A (da) |
| FI (1) | FI67081C (da) |
| FR (1) | FR2471381A1 (da) |
| HU (1) | HU185020B (da) |
| IE (1) | IE51187B1 (da) |
| IL (1) | IL61614A (da) |
| IT (1) | IT1196411B (da) |
| SU (1) | SU1034606A3 (da) |
| YU (1) | YU309080A (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2120242A (en) * | 1982-04-30 | 1983-11-30 | Erba Farmitalia | Ergoline derivatives |
| CH649998A5 (de) * | 1982-08-09 | 1985-06-28 | Sandoz Ag | Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff. |
| DE3413660A1 (de) * | 1984-04-09 | 1985-10-17 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur herstellung von 2-(trialkyl-silyl)-ergolinderivaten |
| DE3587860D1 (de) * | 1984-04-09 | 1994-07-28 | Schering Ag | 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. |
| GB8427536D0 (en) * | 1984-10-31 | 1984-12-05 | Lilly Industries Ltd | Ergoline derivatives |
| US4675322A (en) * | 1984-12-10 | 1987-06-23 | Eli Lilly And Company | 1-Substituted-6-n-propyl-8β-methylthio-methylergolines |
| US4683313A (en) * | 1985-06-24 | 1987-07-28 | Eli Lilly And Company | 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles |
| US4801712A (en) * | 1985-06-24 | 1989-01-31 | Eli Lilly And Company | 2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity |
| DE3535930A1 (de) * | 1985-10-04 | 1987-04-09 | Schering Ag | Neue 2-substituierte ergolinderivate |
| GB8615471D0 (en) * | 1986-06-25 | 1986-07-30 | Erba Farmitalia | T-butyl ergoline derivatives |
| DE3938701A1 (de) * | 1989-11-20 | 1991-05-23 | Schering Ag | Neue agroclavin- und elymoclavin-derivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln |
| TW252979B (da) * | 1992-12-24 | 1995-08-01 | Erba Carlo Spa |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL278401A (da) * | 1961-05-29 | |||
| US3228943A (en) * | 1962-06-11 | 1966-01-11 | Lumilysergol derivatives | |
| US3646046A (en) * | 1968-03-07 | 1972-02-29 | Farmaceutici Italia | 1 6-dimethyl-10alpha-ergoline derivatives |
| IE41533B1 (en) * | 1974-03-14 | 1980-01-30 | Sandoz Ltd | Thiomethyl ergolene derivatives |
| US3901894A (en) * | 1974-06-06 | 1975-08-26 | Lilly Co Eli | 8-thiomethylergolines |
| US3968111A (en) * | 1974-12-06 | 1976-07-06 | Eli Lilly And Company | 8,8-Disubstituted-6-methylergolines and related compounds |
| US3959288A (en) * | 1974-12-13 | 1976-05-25 | Eli Lilly And Company | 8-Oxymethylergolines and process therefor |
| IT1192260B (it) * | 1977-07-05 | 1988-03-31 | Simes | Derivati di ergoline-2-tioeteri e loro solfossidi |
| US4166182A (en) * | 1978-02-08 | 1979-08-28 | Eli Lilly And Company | 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
| IT1094965B (it) * | 1978-04-05 | 1985-08-10 | Corvi Mora E | Procedimento di preparazione di derivati del lisergolo |
-
1980
- 1980-12-01 US US06/211,920 patent/US4382940A/en not_active Expired - Lifetime
- 1980-12-02 AU AU64958/80A patent/AU537581B2/en not_active Ceased
- 1980-12-02 IL IL61614A patent/IL61614A/xx unknown
- 1980-12-02 FI FI803736A patent/FI67081C/fi not_active IP Right Cessation
- 1980-12-02 DE DE8080107522T patent/DE3068911D1/de not_active Expired
- 1980-12-02 CA CA000365922A patent/CA1153367A/en not_active Expired
- 1980-12-02 EP EP80107522A patent/EP0030351B1/en not_active Expired
- 1980-12-02 FR FR8025571A patent/FR2471381A1/fr active Granted
- 1980-12-04 DK DK518580A patent/DK518580A/da not_active Application Discontinuation
- 1980-12-05 YU YU03090/80A patent/YU309080A/xx unknown
- 1980-12-05 SU SU803212054A patent/SU1034606A3/ru active
- 1980-12-05 IE IE2558/80A patent/IE51187B1/en unknown
- 1980-12-05 IT IT26488/80A patent/IT1196411B/it active
- 1980-12-05 HU HU802916A patent/HU185020B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SU1034606A3 (ru) | 1983-08-07 |
| FR2471381A1 (fr) | 1981-06-19 |
| IL61614A (en) | 1984-04-30 |
| FR2471381B1 (da) | 1983-01-07 |
| HU185020B (en) | 1984-11-28 |
| CA1153367A (en) | 1983-09-06 |
| EP0030351A3 (en) | 1981-12-02 |
| EP0030351A2 (en) | 1981-06-17 |
| IL61614A0 (en) | 1981-01-30 |
| FI67081B (fi) | 1984-09-28 |
| IT8026488A0 (it) | 1980-12-05 |
| DE3068911D1 (en) | 1984-09-13 |
| EP0030351B1 (en) | 1984-08-08 |
| US4382940A (en) | 1983-05-10 |
| AU6495880A (en) | 1981-06-11 |
| YU309080A (en) | 1983-02-28 |
| IE51187B1 (en) | 1986-10-29 |
| IE802558L (en) | 1981-06-06 |
| IT1196411B (it) | 1988-11-16 |
| FI803736L (fi) | 1981-06-07 |
| DK518580A (da) | 1981-06-07 |
| AU537581B2 (en) | 1984-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI67081C (fi) | Analogifoerfarande foer framstaellning av ergolinderivat | |
| EP0241053B1 (en) | Aryl-substituted (n-piperidinyl)-methyl- and (n-piperazinyl) methylazoles having antipsychotic properties | |
| Sarges et al. | A novel class of" GABAergic" agents: 1-aryl-3-(aminoalkylidene) oxindoles | |
| IE56541B1 (en) | Novel ergolinyl compounds nitrogen-substituted in the 8-position,their preparation,and use as medicinal agents | |
| DK149855B (da) | Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater | |
| IT8249295A1 (it) | Composti di 1,4-diidropiridina | |
| CA1125657A (en) | Derivatives of 1,2,3,3a,8,8a-hexadydropyrrolo ¬2,3-b| indole | |
| FI84069B (fi) | Foerfarande foer framstaellning av en terapeutiskt aktiv heterocyklisk aminofoerening. | |
| Chen et al. | Dihydro-1, 4-dithiin annelation | |
| US4268513A (en) | Pyrrolo [3,4-c]quinoline compounds and pharmaceutical compositions, methods for their use and preparation | |
| Press et al. | Thiophene systems. 5. Thieno [3, 4-b][1, 5] benzoxazepines, thieno [3, 4-b][1, 5] benzothiazepines, and thieno [3, 4-b][1, 4] benzodiazepines as potential central nervous system agents | |
| US4440768A (en) | Hexahydropyrrolo[3,4-c]quinoline compounds and pharmaceutical compositions, and methods for their use | |
| DK170099B1 (da) | t-Butyl-ergolin-derivativer, fremgangsmåde til fremstilling deraf, samt farmaceutiske præparater indeholdende disse | |
| US4350814A (en) | Pyrrolo [3,4-c]quinoline compounds | |
| HINo et al. | Bromination of 2-Bromo, 2-Ethylthio, and 2-Ethylsulfonylindoles with N-Bromosuccinimide. Isolation and Reactions of 1-Bromoindoles and 3-Bromoindolenines | |
| US4028356A (en) | Triazinobenzodiazepines | |
| IE881214L (en) | Fused heteroalkylene quinolinamines, a process and¹intermediates for their preparation and their use as¹medicaments | |
| US4500708A (en) | Benzothiazine derivatives | |
| NO774216L (no) | Fremgangsmaate for fremstilling av benzimidazolderivater | |
| CS215144B2 (cs) | Způsob výroby derivátů ergolinu | |
| KR800001551B1 (ko) | 환상 화합물의 제조방법 | |
| US3575965A (en) | Process for the preparation of 11-chloro-8,12b-dihydro - 2,8 -dimethyl-12b-phenyl-4h - (1,3)oxazino(3,2-d) (1,4)benzodiazepine-4,7 (6h)-dione | |
| US4672062A (en) | 3-amino-2,3-dihydro-1-benzoxepine compounds and pharmaceutical compositions containing them | |
| FI84828B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla substituerade 1,8-naftyridinoner. | |
| Daukshas et al. | Acylation of o-methoxybenzodioxaheterocycles and synthesis of β-amino ketones from acetyl derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: FARMITALIA CARLO ERBA S.P.A. |